Clinical trial
A Phase II, Dose-Finding Study With ASP2151 in Subjects With Recurrent Episodes of Genital HErpes
NCT00486200 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II, Dose-Finding Study With ASP2151 in Subjects With Recurrent Episodes of Genital HErpes
- Lead sponsor
- Astellas Pharma Inc
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 21, 2007
- Completion date
- August 12, 2008
- Enrollment
- 695 (actual)
- Sites
- 25
Conditions
As the registry lists them; a condition with its own page is linked.